sharecast

{{ storiesRelated.title }}

Fidelity Top Stories
09 Sep
BT Tower, telecoms
BT rallies as private equity firms said to consider takeover

BT shares rallied on Wednesday following a report that its executives are working with advisers to defend against potential takeovers and approaches from activists following a slump in the share price.

09 Sep
retail consumer shopping black friday bullring hammerson
Hammerson is most shorted UK company, alongside Metro Bank and Sainsbury's

Hammerson is the most shorted UK listed company as investors bet against the beleaguered shopping centre operator, research shows.

09 Sep
ep fitch mantienela comunitat valencianacalificacion bbb- con perspectiva establela deudalargo plazo
Fitch now assumes UK will quit Europe without trade deal - report

Credit ratings agency Fitch has changed its outlook and now believes the UK with leave the European Union without a trade deal in place, it emerged on Wednesday.

09 Sep
Nicola Sturgeon Escocia
Scotland and Wales warn new internal market bill harms UK unity

Scotland and Wales warned on Wednesday that the new internal market bill that was proposed by the British government will undermine the UK’s unity as it will steal power from Scotland, Wales and Northern Ireland.

09 Sep
Biffa holds guidance as August revenues, profits recover

Waste management firm Biffa said revenues had recovered to 90% of full year levels with underlying profits improving monthly as it maintained annual guidance.

09 Sep
Avon Rubber buys Team Wendy for $130m as FY guidance held

Avon Rubber said it was buying US-based military helmet maker Team Wendy for $130m (£100m) as it maintained full year guidance.

09 Sep
l-ue-reserve-au-moins-300-millions-de-doses-du-vaccin-covid-19-developpe-par-astrazeneca
AstraZeneca pauses Covid-19 vaccine trial to review safety data

AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a "potentially unexplained illness" in one of the participants.